Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Emergent Biosolutions Inc (NYSE: EBS) closed at $4.66 down -5.28% from its previous closing price of $4.92. In other words, the price has decreased by -$5.28 from its previous closing price. On the day, 1.31 million shares were traded. EBS stock price reached its highest trading level at $4.94 during the session, while it also had its lowest trading level at $4.535.
Ratios:
For a deeper understanding of Emergent Biosolutions Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.07. For the most recent quarter (mrq), Quick Ratio is recorded 1.77 and its Current Ratio is at 3.69. In the meantime, Its Debt-to-Equity ratio is 1.40 whereas as Long-Term Debt/Eq ratio is at 1.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On August 22, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16.
The Benchmark Company Upgraded its Hold to Buy on March 07, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 12 ’25 when Fowler Neal Franklin sold 35,000 shares for $5.83 per share. The transaction valued at 204,050 led to the insider holds 101,100 shares of the business.
Zoon Kathryn C sold 10,000 shares of EBS for $57,300 on Mar 12 ’25. The Director now owns 44,482 shares after completing the transaction at $5.73 per share. On Mar 12 ’25, another insider, Fowler Neal Franklin, who serves as the Director of the company, bought 35,000 shares for $5.83 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 253210416 and an Enterprise Value of 829810560. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24 while its Price-to-Book (P/B) ratio in mrq is 0.52. Its current Enterprise Value per Revenue stands at 0.795 whereas that against EBITDA is 15.54.
Stock Price History:
The Beta on a monthly basis for EBS is 2.14, which has changed by 1.026087 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, EBS has reached a high of $15.10, while it has fallen to a 52-week low of $1.82. The 50-Day Moving Average of the stock is -42.09%, while the 200-Day Moving Average is calculated to be -46.59%.
Shares Statistics:
For the past three months, EBS has traded an average of 1.18M shares per day and 1052480 over the past ten days. A total of 54.30M shares are outstanding, with a floating share count of 52.32M. Insiders hold about 3.72% of the company’s shares, while institutions hold 63.92% stake in the company. Shares short for EBS as of 1741910400 were 9156033 with a Short Ratio of 7.74, compared to 1739491200 on 7094646. Therefore, it implies a Short% of Shares Outstanding of 9156033 and a Short% of Float of 17.02.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
